vMYX-hIL-12/Dec

N/A

Report date: 2024/03/21 13:54:13

Base Information

Drug NamevMYX-hIL-12/Dec
Drug Alias NamevMYX-hIL-12/Dec
ClassificationCell and gene therapy > Gene therapyBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityDecorin gene transference +[4] 
TargetsDecorinInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoMyx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncoMyx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A